CDKN2A and neoplasm: Furthermore, although high tumor mutational burden (TMB) was associated with better prognosis in a previous study of patients with resected LUAD [23], there was no significant difference in TMB between CDKN2A/BHD tumors and CDKN2A/BWT tumors in the TCGA‐LUAD cohort (Fig. 2E).